Bufalin induces protective autophagy by Cbl‐b regulating mTOR and ERK signaling pathways in gastric cancer cells. (27th December 2018)

• Record Type: Journal Article
• Authors: Qi, Hai‐Yan; Qu, Xiu‐Juan; Liu, Jing; Hou, Ke‐Zuo; Fan, Yi‐Bo; Che, Xiao‐Fang; Liu, Yun‐Peng
• Is Part Of: Cell biology international. Volume 43:Number 1(2019)
• Page Start: 33
• Page End: 43
• Publication Date: 2018-12-27
• Subjects: apoptosis -- Atg -- autophagy -- bufalin -- cancer therapy -- LC3; Cytology -- Periodicals; Cells -- Periodicals; 571.605
• DOI: 10.1002/cbin.11076
• Languages: English
• ISSNs: 1065-6995

Abstract

Abstract: Bufalin, a natural small‐molecule compound derived from the traditional Chinese medicine Chan su, has shown promising anti‐cancer effects against a broad variety of cancer cells through different mechanisms. It has been reported to induce autophagy in gastric cancer cells. However, the molecular mechanism involved is not fully elucidated. In the present study, we aimed to investigate the molecular mechanism by which bufalin induce autophagy in human gastric cancer cells. We found that bufalin induced apoptosis and autophagy in gastric cancer cells, and autophagy prevented human gastric cancer cells from undergoing apoptosis. Bufalin treatment changed the expression of autophagy‐related proteins. Moreover, phosphorylated Akt, mTOR, and p70S6K were all significantly decreased, while phosphorylated ERK1/2 was increased by bufalin. Pretreatment of MGC803 cells with the ERK1/2‐specific inhibitor PD98059 led to the down‐regulation of LC3 II. Further study showed that Cbl‐b positively regulated autophagy by suppressing mTOR and enhancing ERK1/2 activation. Therefore, our data provide evidence that bufalin induces autophagy in MGC803 cells via both Akt/mTOR/p70S6K and ERK signaling pathways, and Cbl‐b‐mediated suppression of mTOR and activation of ERK1/2 might play an important role.